PL BioScience GmbH: PL BioScience and Macopharma enter into a Patent License and Assignment Agreement regarding Human Platelet Lysate (HPL) cell culture supplements.

The companies agree to a worldwide Human Platelet Lysate (HPL) Patent License and Assignment Agreement, including redirection of HPL customers from Macopharma to PL BioScience. PL BioScience GmbH

Related Keywords

Germany ,Poland ,Tunisia ,France ,Tourcoing ,Nord Pas De Calais ,German ,French ,Hatim Hemeda ,Bioscience Gmb , ,Human Platelet Lysate ,Patent License ,Assignment Agreement ,Science Gmbh ,Kbioscience ,Mbh ,Acopharma ,Winter ,Patent ,License ,Assignment ,Agreement ,Egarding ,Human ,Platelet ,Lysate ,Fell ,Culture ,Supplements ,